Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hua Tuo Zai Zao Wan for stable angina in coronary heart disease
ChiCTR2300070770Phase 4Completed
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Oct 2009
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Huatuo Zaizao in coronary arteriosclerosis and stable angina (4 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Change from baseline in frequency of angina attacks and Overall efficacy rate for angina pectoris. Started Oct 2009; status: completed.
02
Drugs
Huatuo Zaizao
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on ChiCTR2300070770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070770.